购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Dehydrogenase
    (1)
  • Parasite
    (1)
  • Others
    (4)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 35日内发货
    (1)
  • 6-8周
    (2)
  • 10-14周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "nifurtimox"的结果
筛选
搜索结果
TargetMol产品目录中 "

nifurtimox

"的结果
  • 抑制剂&激动剂
    5
    TargetMol | Inhibitors_Agonists
  • 分子与细胞研究
    1
    TargetMol | Inhibitors_Agonists
  • Nifurtimox
    硝呋替莫, BAY-2502, BAY-A-2502
    T532523256-30-6
    Nifurtimox (BAY-A-2502) 是一种用于锥虫病的抗虫剂,可影响乳酸脱氢酶活性。它有潜力研究神经母细胞瘤细胞。
    • ¥ 170
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • 12-methyl Myristic Acid methyl ester
    T372555129-66-8
    12-methyl Myristic acid methyl ester is a methylated fatty acid methyl ester that has been found in vermicomposts of cattle manure, carica papaya leaves, and cuticular wax of K. africana. It is a volatile compound in lipid-lowering granulated tea. Levels of 12-methyl myristic acid methyl ester are decreased in T. cruzi treated with nifurtimox compared to non-treated controls.
    • ¥ 577
    35日内发货
    规格
    数量
  • Antitrypanosomal agent 6
    T62710
    Antitrypanosomal agent 6 (compound 18a) 是一种有效的抗锥体虫剂,表现出良好的 ADME 特性。Antitrypanosomal agent 6 抗布氏锥虫 (T. brucei) 的活性比 Nifurtimox 高两倍以上,IC50为 0.47 μM。Antitrypanosomal agent 6 与 DNA 具有很强的相互作用,可以选择性的结合富含 AT 碱基的 DNA。
    • ¥ 10600
    10-14周
    规格
    数量
  • Antitrypanosomal agent 7
    T631672492436-38-9
    Antitrypanosomal agent 7 (compound 18c) 是一种有效的抗锥体虫剂,显示出良好的 ADME 特性。Antitrypanosomal agent 7 的抗布氏锥虫 (T. brucei) 的活性 (IC50: 0.71 μM),比 Nifurtimox 高两倍以上。Antitrypanosomal agent 7 与 DNA 有很强的相互作用,且能够选择性结合富含 AT 碱基的 DNA。
    • ¥ 10600
    6-8周
    规格
    数量
  • RKS-262
    T715491041469-97-9
    RKS262 is a specific cyclin CDK inhibitor. RKS262 was identified by structural optimization of Nifurtimox which is currently undergoing phase II clinical trials to treat high-risk neuroblastoma. In a NCI(60) cell-line assay RKS262 exhibited significant cytotoxicity in ovarian cancer cells and a variety of other cell lines exceeding effects of commercial drugs such as cisplatin, 5-FU, cyclophosphamide or sapacitabine. Various leukemia cell-lines were most sensitive (GI(50): ~ 10 nM) while several non-small cell lung cancer cell lines and few cell lines from other tissues were relatively resistant (GI(50) > 1 µM) to RKS262 treatment.
    • ¥ 10600
    6-8周
    规格
    数量